Last 7 days
8.9%
Last 30 days
55.1%
Last 90 days
20.4%
Trailing 12 Months
2.5%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 227.8M | 235.5M | 245.1M | 0 |
2022 | 163.1M | 184.2M | 203.6M | 215.8M |
2021 | 113.0M | 126.8M | 132.3M | 146.2M |
2020 | 65.8M | 73.4M | 90.1M | 101.1M |
2019 | 40.0M | 47.1M | 54.4M | 60.1M |
2018 | 18.1M | 21.8M | 25.4M | 32.6M |
2017 | 0 | 0 | 10.8M | 14.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 05, 2023 | werner robert f. | sold (taxes) | -3,725 | 24.67 | -151 | chief accounting officer |
Dec 05, 2023 | green paula | sold (taxes) | -22,943 | 24.67 | -930 | svp of human resources |
Dec 05, 2023 | cho dennis | sold (taxes) | -6,414 | 24.67 | -260 | see remarks |
Dec 05, 2023 | banyai william | sold (taxes) | -19,119 | 24.67 | -775 | see remarks |
Dec 05, 2023 | leproust emily m. | sold (taxes) | -57,456 | 24.67 | -2,329 | chief executive officer |
Nov 20, 2023 | banyai william | sold (taxes) | -23,948 | 24.74 | -968 | see remarks |
Nov 20, 2023 | leproust emily m. | sold (taxes) | -65,857 | 24.74 | -2,662 | chief executive officer |
Nov 20, 2023 | thorburn james m | sold (taxes) | -25,432 | 24.74 | -1,028 | chief financial officer |
Nov 20, 2023 | green paula | sold (taxes) | -9,228 | 24.74 | -373 | svp of human resources |
Nov 20, 2023 | finn patrick john | sold (taxes) | -25,432 | 24.74 | -1,028 | president and coo |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | added | 94.12 | 2,568,040 | 5,352,770 | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 4.85 | 38,208 | 1,037,480 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | new | - | 304,203 | 304,203 | 0.01% |
Nov 21, 2023 | COMERICA BANK | new | - | 46,395 | 46,395 | -% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | reduced | -90.00 | -96.00 | 31.00 | -% |
Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | added | 11.5 | 102,365 | 1,085,750 | -% |
Nov 15, 2023 | Tudor Investment Corp Et Al | sold off | -100 | -575,990 | - | -% |
Nov 15, 2023 | JANE STREET GROUP, LLC | reduced | -38.45 | -1,035,910 | 1,616,890 | -% |
Nov 15, 2023 | Capital Impact Advisors, LLC | added | 8.95 | 68,242 | 933,925 | 1.56% |
Nov 15, 2023 | MORGAN STANLEY | added | 22.69 | 4,006,520 | 22,645,400 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 08, 2023 | integrated core strategies (us) llc | 5.3% | 3,042,960 | SC 13G | |
Apr 10, 2023 | vanguard group inc | 10.02% | 5,697,547 | SC 13G/A | |
Apr 06, 2023 | blackrock inc. | 10.9% | 6,212,913 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 1.2% | 704,000 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.24% | 5,229,345 | SC 13G/A | |
Feb 03, 2023 | state street corp | 7.82% | 4,426,249 | SC 13G | |
Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 5.18% | 2,934,033 | SC 13G | |
Jan 24, 2023 | blackrock inc. | 9.7% | 5,487,180 | SC 13G/A | |
Jan 13, 2023 | jpmorgan chase & co | 6.7% | 3,829,962 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 07, 2023 | 4 | Insider Trading | |
Dec 07, 2023 | 4 | Insider Trading | |
Dec 07, 2023 | 4 | Insider Trading | |
Dec 07, 2023 | 4 | Insider Trading | |
Dec 07, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 160.7B | 29.6B | 10.51% | -19.98% | 27.16 | 5.44 | -5.39% | -12.54% |
IDXX | 44.1B | 3.6B | 24.23% | 23.99% | 53.65 | 12.3 | 7.43% | 22.86% |
A | 37.3B | 7.0B | 16.28% | -18.61% | 32.89 | 5.33 | 5.03% | -14.68% |
DGX | 15.2B | 9.3B | 1.84% | -9.68% | 19.95 | 1.64 | -9.69% | -38.22% |
EXAS | 11.7B | 2.4B | 2.99% | 40.82% | -41.48 | 4.86 | 19.99% | 60.62% |
MID-CAP | ||||||||
CRL | 10.5B | 4.2B | 16.20% | -2.67% | 22.08 | 2.49 | 11.49% | 8.84% |
MEDP | 8.7B | 1.8B | 2.84% | 34.94% | 31.81 | 4.88 | 29.62% | 20.49% |
NTRA | 6.9B | 988.7M | 40.66% | 50.03% | -13.86 | 7 | 27.41% | 8.51% |
NEOG | 3.9B | 919.1M | 17.21% | 17.06% | -147.97 | 4.28 | 73.02% | -172.93% |
GH | 3.0B | 535.8M | 8.75% | -45.64% | -7.02 | 5.66 | 24.38% | 26.34% |
SMALL-CAP | ||||||||
CDNA | 531.2M | 297.1M | 54.98% | -22.82% | -5.87 | 1.79 | -6.74% | -21.60% |
ACRS | 71.5M | 21.4M | -81.47% | -93.49% | -0.62 | 3.34 | -8.80% | -39.66% |
AWH | 31.2M | 9.2M | -11.33% | -33.68% | -1.76 | 3.4 | 16.43% | 48.38% |
APDN | 12.0M | 13.4M | -4.35% | -39.31% | -1.21 | 0.9 | -26.43% | -20.54% |
BIOC | 120.4K | - | -82.76% | -93.43% | 0 | 0.76 | -57.78% | -93.13% |
Income Statement (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 5.0% | 66,946,000 | 63,740,000 | 60,180,000 | 54,243,000 | 57,306,500 | 56,113,000 | 48,127,000 | 42,018,000 | 37,950,500 | 35,018,000 | 31,204,000 | 28,161,000 | 32,432,000 | 21,207,000 | 19,297,000 | 17,164,000 | 15,736,500 | 13,600,000 | 13,557,000 | 11,492,000 | 8,407,000 |
Cost Of Revenue | 1.4% | 42,424,000 | 41,845,000 | 41,669,000 | 29,442,000 | 31,586,000 | 30,974,000 | 29,714,000 | 27,056,000 | 22,497,000 | 20,933,000 | 19,028,000 | 18,162,000 | 17,577,500 | 16,472,000 | 13,564,000 | 13,792,000 | 12,385,500 | 11,394,000 | 11,789,000 | 11,857,000 | 9,093,000 |
Costs and Expenses | -6.0% | 117,057,500 | 124,521,000 | 121,817,000 | 98,873,000 | 114,177,500 | 117,276,000 | 108,929,000 | 97,958,000 | 77,761,500 | 77,136,000 | 69,208,000 | 60,954,000 | 56,399,000 | 49,403,000 | 51,383,000 | 72,994,000 | 47,305,000 | 41,721,000 | 39,820,000 | 34,389,000 | 28,111,000 |
S&GA Expenses | 2.9% | 47,391,500 | 46,057,000 | 53,965,000 | 42,324,000 | 54,159,500 | 53,693,000 | 53,998,000 | 51,098,000 | 38,242,500 | 34,478,000 | 34,389,000 | 28,792,000 | 27,185,000 | 22,487,000 | 27,190,000 | 26,405,000 | 24,423,000 | 21,320,000 | 19,124,000 | 15,259,000 | 12,953,000 |
R&D Expenses | -3.2% | 23,745,500 | 24,528,000 | 27,379,000 | 31,242,000 | 29,606,000 | 36,840,000 | 31,231,000 | 22,630,000 | 19,443,000 | 19,838,000 | 15,791,000 | 14,000,000 | 11,636,500 | 10,444,000 | 10,629,000 | 10,297,000 | 10,496,500 | 9,007,000 | 8,907,000 | 7,273,000 | 6,065,000 |
EBITDA Margin | 8.1% | -0.71 | -0.77 | -0.83 | -0.91 | -1.04 | -1.11 | -1.15 | -1.14 | -1.09 | -1.01 | -1.01 | -1.08 | -1.47 | -1.90 | -2.11 | - | - | - | - | - | - |
Interest Expenses | 0% | 1,000 | 1,000 | 2,000 | 1,000 | 25,500 | - | 29,000 | 26,000 | 83,500 | 70,000 | 95,000 | 118,000 | 143,000 | 181,000 | 215,000 | 248,000 | 287,500 | 318,000 | 340,000 | 348,000 | 386,000 |
Income Taxes | -128.0% | -174,000 | 622,000 | 676,000 | 76,000 | 303,000 | -149,000 | -149,000 | -10,405,000 | 370,500 | -2,377,000 | 61,000 | 46,000 | 262,500 | 21,000 | 61,000 | 37,000 | 112,000 | 54,000 | 84,000 | 43,000 | 76,000 |
Earnings Before Taxes | 18.2% | -46,465,000 | -56,773,000 | -58,480,000 | -41,748,000 | -50,823,000 | -60,666,000 | -60,817,000 | -55,968,000 | -40,901,500 | -42,414,000 | -37,858,000 | -32,854,000 | -24,055,500 | -28,186,000 | -31,707,000 | -55,601,000 | -31,069,000 | -27,862,000 | -25,849,000 | -22,596,000 | -19,726,000 |
EBT Margin | 5.9% | -0.83 | -0.88 | -0.93 | -0.99 | -1.12 | -1.19 | -1.23 | -1.21 | -1.16 | -1.08 | -1.09 | -1.16 | -1.55 | -2.00 | -2.22 | - | - | - | - | - | - |
Net Income | 19.4% | -46,243,000 | -57,395,000 | -59,156,000 | -41,824,000 | -51,115,000 | -60,517,000 | -60,668,000 | -45,563,000 | -41,242,000 | -40,037,000 | -37,919,000 | -32,900,000 | -24,318,000 | -28,207,000 | -31,768,000 | -55,638,000 | -31,181,000 | -27,916,000 | -25,933,000 | -22,639,000 | -19,802,000 |
Net Income Margin | 6.2% | -0.83 | -0.89 | -0.93 | -0.99 | -1.07 | -1.13 | -1.15 | -1.13 | -1.15 | -1.07 | -1.09 | -1.16 | -1.55 | -2.00 | -2.23 | - | - | - | - | - | - |
Free Cashflow | 17.3% | -23,097,000 | -27,921,000 | -53,341,000 | -65,894,000 | -17,729,000 | -74,767,000 | -74,310,000 | -59,436,000 | -42,892,000 | -34,902,000 | -32,950,000 | -28,561,000 | -27,427,000 | -26,316,000 | -61,408,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -4.2% | 776 | 810 | 854 | 910 | 961 | 980 | 1,022 | 786 | 702 | 725 | 677 | 700 | 399 | 408 | 324 | 192 | 187 | 207 | 140 | 164 | 116 |
Current Assets | -4.8% | 424 | 446 | 489 | 542 | 596 | 624 | 664 | 385 | 546 | 577 | 608 | 634 | 335 | 345 | 260 | 129 | 160 | 183 | 121 | 147 | 96.00 |
Cash Equivalents | -5.9% | 289 | 307 | 315 | 317 | 379 | 378 | 409 | 193 | 467 | 477 | 401 | 350 | 94.00 | 209 | 185 | 27.00 | 47.00 | 69.00 | 29.00 | 67.00 | 82.00 |
Inventory | -11.8% | 32.00 | 36.00 | 40.00 | 45.00 | 39.00 | 43.00 | 45.00 | 40.00 | 32.00 | 21.00 | 16.00 | 13.00 | 12.00 | 13.00 | 11.00 | 7.00 | 7.00 | 5.00 | 4.00 | 6.00 | 6.00 |
Net PPE | -6.4% | 132 | 141 | 147 | 145 | 139 | 127 | 92.00 | 65.00 | 44.00 | 38.00 | 32.00 | 27.00 | 25.00 | 24.00 | 23.00 | 21.00 | 21.00 | 20.00 | 15.00 | 14.00 | 12.00 |
Goodwill | 0% | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 84.00 | 22.00 | 23.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 0.1% | 153 | 153 | 150 | 164 | 172 | 159 | 158 | 160 | 121 | 115 | 63.00 | 62.00 | 63.00 | 59.00 | 60.00 | 89.00 | 35.00 | 31.00 | 25.00 | 26.00 | 27.00 |
Current Liabilities | 0.7% | 73.00 | 73.00 | 72.00 | 84.00 | 91.00 | 93.00 | 85.00 | 80.00 | 63.00 | 55.00 | 40.00 | 37.00 | 36.00 | 31.00 | 30.00 | 58.00 | 30.00 | 25.00 | 19.00 | 19.00 | 19.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 2.00 | 3.00 | 4.00 | 4.00 | 5.00 | 6.00 | 7.00 | 7.00 |
Shareholder's Equity | -5.2% | 623 | 658 | 704 | 746 | 789 | 821 | 863 | 626 | 581 | 610 | 614 | 638 | 336 | 349 | 264 | 103 | 152 | 176 | 115 | 139 | - |
Retained Earnings | -4.7% | -1,033 | -986 | -929 | -870 | -828 | -777 | -716 | -656 | -610 | -569 | -529 | -491 | -458 | -434 | -405 | -374 | -318 | -287 | -259 | -233 | -210 |
Additional Paid-In Capital | 0.7% | 1,657 | 1,645 | 1,633 | 1,617 | 1,620 | 1,599 | 1,581 | 1,282 | 1,191 | 1,179 | 1,143 | 1,129 | 795 | 783 | 670 | 477 | 470 | 463 | 375 | 372 | 9.00 |
Shares Outstanding | 0.3% | 58.00 | 57.00 | 57.00 | 57.00 | 57.00 | 53.00 | 53.00 | 50.00 | 49.00 | 49.00 | 47.00 | 46.00 | 39.00 | 37.00 | 37.00 | 33.00 | 27.00 | 30.00 | 24.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 11.6% | -20,704,000 | -23,412,000 | -44,288,000 | -54,070,000 | -1,267,000 | -34,125,000 | -42,340,000 | -46,653,000 | -34,803,000 | -27,960,000 | -24,549,000 | -24,932,000 | -25,202,000 | -23,468,000 | -58,671,000 | -34,914,000 | -23,358,000 | -22,082,000 | -20,813,000 | -21,684,000 | -16,696,000 |
Share Based Compensation | 10.9% | 11,747,000 | 10,597,000 | 10,259,000 | -2,325,000 | 19,048,000 | 20,043,000 | 22,465,000 | 18,108,000 | 9,247,000 | 9,176,000 | 11,553,000 | 7,022,000 | 5,131,000 | 4,071,000 | 4,197,000 | 3,697,000 | 3,363,000 | 3,032,000 | 2,911,000 | 1,864,000 | 1,086,000 |
Cashflow From Investing | -112.0% | -2,247,000 | 18,670,000 | 41,160,000 | -6,971,000 | 2,783,000 | 4,163,000 | -13,294,000 | -226,582,000 | 23,911,000 | 104,575,000 | 73,590,000 | -45,921,000 | -94,669,000 | -61,149,000 | 28,763,000 | 12,405,000 | -1,187,000 | -22,706,000 | -15,160,000 | -65,757,000 | 404,000 |
Cashflow From Financing | 166.9% | 442,000 | -661,000 | 1,525,000 | -395,000 | 1,240,000 | -1,311,000 | 271,616,000 | -1,011,000 | 1,575,000 | -765,000 | 1,451,000 | 326,921,000 | 5,574,000 | 108,064,000 | 188,037,000 | 2,057,000 | 2,928,000 | 84,285,000 | -1,634,000 | 72,999,000 | 6,583,000 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||||
---|---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2021 | |||
Statement of Comprehensive Income [Abstract] | |||||
Revenues [1] | [1] | $ 245,109 | $ 203,565 | $ 132,333 | |
Operating expenses: | |||||
Cost of revenues | 155,380 | 119,330 | 80,620 | ||
Research and development | 106,894 | 120,307 | 69,072 | ||
Selling, general and administrative | 189,738 | 212,949 | 135,901 | ||
Restructuring and other costs | 16,169 | 0 | 0 | ||
Change in fair value of contingent considerations and holdbacks | (5,913) | (14,245) | (534) | ||
Total operating expenses | 462,268 | 438,341 | 285,059 | ||
Loss from operations | (217,159) | (234,776) | (152,726) | ||
Interest income | 14,365 | 3,062 | 435 | ||
Interest expense | (5) | (80) | (367) | ||
Gain on deconsolidation of subsidiary | 0 | 4,607 | 0 | ||
Other income (expense), net | (667) | (1,087) | (1,370) | ||
Loss before income taxes | (203,466) | (228,274) | (154,028) | ||
(Provision for) benefit from income taxes | (1,152) | 10,411 | 1,930 | ||
Net loss attributable to common stockholders | (204,618) | (217,863) | (152,098) | ||
Other comprehensive loss: | |||||
Change in unrealized gain (loss) on investments | 1,510 | (1,594) | (14) | ||
Foreign currency translation adjustment | (423) | (795) | 473 | ||
Comprehensive loss | $ (203,531) | $ (220,252) | $ (151,639) | ||
Net loss per share attributable to common stockholders—basic (in dollars per share) | $ (3.60) | $ (4.04) | $ (3.15) | ||
Net loss per share attributable to common stockholders—diluted (in dollars per share) | $ (3.60) | $ (4.04) | $ (3.15) | ||
Weighted average shares used in computing net loss per share attributable to common stockholders—basic (in shares) | 56,885 | 53,885 | 48,251 | ||
Weighted average shares used in computing net loss per share attributable to common stockholders—diluted (in shares) | 56,885 | 53,885 | 48,251 | ||
|
Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Sep. 30, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 286,470 | $ 378,687 |
Short-term investments | 49,943 | 126,281 |
Accounts receivable, net | 44,064 | 40,294 |
Inventories | 32,063 | 39,307 |
Prepaid expenses and other current assets | 11,716 | 11,914 |
Total current assets | 424,256 | 596,483 |
Property and equipment, net | 131,830 | 139,441 |
Operating lease right-of-use assets | 71,531 | 74,948 |
Goodwill | 85,811 | 85,811 |
Intangible assets, net | 54,483 | 59,738 |
Restricted cash, non-current | 2,811 | 1,572 |
Other non-current assets | 5,681 | 3,385 |
Total assets | 776,403 | 961,378 |
Current liabilities: | ||
Accounts payable | 14,052 | 20,092 |
Accrued expenses | 10,754 | 10,169 |
Accrued compensation | 25,818 | 27,023 |
Current portion of operating lease liability | 14,896 | 13,642 |
Other current liabilities | 7,803 | 19,737 |
Total current liabilities | 73,323 | 90,663 |
Operating lease liability, net of current portion | 79,173 | 81,270 |
Other non-current liabilities | 475 | 60 |
Total liabilities | 152,971 | 171,993 |
Commitments and contingencies | ||
Stockholders’ equity | ||
Common stock, $0.00001 par value — 100,000 and 100,000 shares authorized at September 30, 2023 and 2022, respectively; 57,557 and 56,523 shares issued and outstanding at September 30, 2023 and 2022, respectively | 0 | 0 |
Additional paid-in capital | 1,657,222 | 1,619,644 |
Accumulated other comprehensive loss | (756) | (1,843) |
Accumulated deficit | (1,033,034) | (828,416) |
Total stockholders’ equity | 623,432 | 789,385 |
Total liabilities and stockholders’ equity | $ 776,403 | $ 961,378 |
 CEO | Dr. Emily Marine Leproust Ph.D. |
---|---|
 WEBSITE | www.twistbioscience.com |
 EMPLOYEES | 989 |